Drugmakers Try Evasion, Tougher Negotiations to Fight New U.S. Insurer Tactic

By REUTERS
NYT Europe
In the escalating battle over U.S. prescription drug prices, major pharmaceutical companies are scrambling to limit the economic damage from a new U.S. insurer tactic that coaxes patients away from expensive drugs.
Published date: July 5, 2018 at 04:15PM
Reuters
New York Times article